Log in

CNSX:BBM - Blueberries Medical Stock Price, Forecast & News

0.00 (0.00 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
Now: $0.10
50-Day Range
MA: $0.13
52-Week Range N/A
Volume90,787 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Blueberries Cannabis Corp, through its subsidiaries, produces cannabis. The company is headquartered in Ontario, Canada.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive BBM News and Ratings via Email

Sign-up to receive the latest news and ratings for BBM and its competitors with MarketBeat's FREE daily newsletter.

Blueberries Medical (CNSX:BBM) Frequently Asked Questions

What is Blueberries Medical's stock symbol?

Blueberries Medical trades on the CNSX under the ticker symbol "BBM."

What price target have analysts set for BBM?

1 brokerages have issued twelve-month price targets for Blueberries Medical's shares. Their forecasts range from $0.47 to $0.47. On average, they anticipate Blueberries Medical's share price to reach $0.47 in the next twelve months. This suggests a possible upside of 370.0% from the stock's current price. View Analyst Price Targets for Blueberries Medical.

What is the consensus analysts' recommendation for Blueberries Medical?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Blueberries Medical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Blueberries Medical.

Has Blueberries Medical been receiving favorable news coverage?

News articles about BBM stock have been trending somewhat positive this week, according to InfoTrie. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Blueberries Medical earned a daily sentiment score of 0.7 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Blueberries Medical.

Who are some of Blueberries Medical's key competitors?

What other stocks do shareholders of Blueberries Medical own?

Who are Blueberries Medical's key executives?

Blueberries Medical's management team includes the folowing people:
  • Dr. Patricio A. Stocker, Chief Exec. Officer
  • Christian Guillermo Toro Ibler, Exec. Chairman
  • Christopher Donald Reid, Interim Chief Financial Officer
  • Camilo Villalba Gomez, Chief Operating Officer
  • Mr. Eduardo Molinari, Chief Marketing Officer

How do I buy shares of Blueberries Medical?

Shares of BBM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Blueberries Medical's stock price today?

One share of BBM stock can currently be purchased for approximately $0.10.

What is Blueberries Medical's official website?

The official website for Blueberries Medical is http://www.blueberriesmed.com/.

MarketBeat Community Rating for Blueberries Medical (CNSX BBM)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  20 (Vote Outperform)
Underperform Votes:  16 (Vote Underperform)
Total Votes:  36
MarketBeat's community ratings are surveys of what our community members think about Blueberries Medical and other stocks. Vote "Outperform" if you believe BBM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BBM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Featured Article: Pattern Day Trader

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel